Here the authors, using a mouse model of B cell lymphoma, show that UTX is a dosage sensitive tumor suppressor and may be responsible for some of the increased incidence and possibly aggressiveness of male cancers that harbour UTX mutations. The gene discussed is KDM6A; the disease is B-cell non-Hodgkin lymphoma.